Picture of Ergomed logo

ERGO — Ergomed Income Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Ergomed, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue68.386.4119145160
Cost of Revenue
Gross Profit29.539.648.459.165
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses62.772.9104126160
Operating Profit5.5213.514.618.9-0.264
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes4.9912.614.318-0.923
Provision for Income Taxes
Net Income After Taxes5.579.6812.715-6.68
Net Income Before Extraordinary Items
Net Income5.579.6812.715-6.68
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income5.579.6812.715-6.68
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.1470.2050.3410.3210.086